Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-049907
Filing Date
2023-09-19
Accepted
2023-09-19 16:05:32
Documents
1
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7845
  Complete submission text file 0001209191-23-049907.txt   9294
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
Dhanak Dashyant (Reporting) CIK: 0001760682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 231263730